| abstract |
The invention provides a substituted heteroaryl compound, a composition containing the compound and application of the compound, and discloses a heteroaryl compound shown as a formula (I), or a crystal form, a pharmaceutically acceptable salt, a prodrug, a stereoisomer, a hydrate or a solvate of the heteroaryl compound. The heteroaryl compound and the composition containing the heteroaryl compound can be used for regulating Hypoxia Inducible Factor (HIF) and/or endogenous Erythropoietin (EPO), have better pharmacokinetic parameter characteristics, and can improve the drug concentration of the compound in an animal body so as to improve the curative effect and safety of the drug. |